Scrip
Clinica
Scrip Regulatory Affairs
Scrip Clinical Research
AnimalPharm
Email ID
Password
Forgotten your password?
Sign me in automatically next time
Advanced Search
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
Deals
|
M&A
|
Financials
|
Strategy
|
Lifecycle Management
|
Legal
|
GSK focuses on emerging markets as European austerity bites
26 July 2011
Eleanor Malone
eleanor.malone@informa.com
Please Login to read the full article.
Not a subscriber?
Subscribe to Scrip
Request a FREE Trial
RELATED CONTENT
NEWS
Scrip News
Focus on Almirall: partnering, new products and mature markets are key targets
Austerity takes off gloss from Basilea's Toctino forecasts
Comparative efficacy should have a "formal role in drug licensing"
Icon rejects Pfizer's Sandwich, but is hungry for 800 of its staff
Other Informa News
Quarterly results round-up: Alere and Qiagen slash guidance after challenging Q2
Quarterly results round-up: St Jude and Quest cut jobs to rein in costs, Baxter strong again
COMMENT
Scrip Comment
The Great Disappearotech: shrinking before your very eyes
About Us
Getting Started
Subscribe
Free Trial
Advertise
Awards
White Papers
Executive Briefing
Classifieds
Recruitment
JOB OF THE WEEK
Promote your vacancy here
SCRIP's ONLINE DIRECTORY
Classified ads